Urology Times 50 Innovations Series: β3 agonists for overactive bladder

EP: 1.Urology Times 50 Innovations Series: PSA testing

EP: 2.Urology Times 50 Innovations Series: Testosterone therapy

EP: 3.Urology Times 50 Innovations Series: Stem cell–derived therapy for stress urinary incontinence

EP: 4.Urology Times 50 Innovations Series: Tissue engineering and regenerative medicine

EP: 5.50th Anniversary Innovation Celebration: The midurethral sling for stress urinary incontinence

EP: 6.Urology Times 50 Innovations Series: Genetic testing for prostate cancer

EP: 7.Urology Times 50 Innovations Series: Onabotulinumtoxin A for overactive bladder

EP: 8.Urology Times 50 Innovations Series: Clean intermittent catheterization

EP: 9.Urology Times 50 Innovations Series: Viagra for treatment of erectile dysfunction

EP: 10.Urology Times 50 Innovations Series: Active surveillance for prostate cancer

EP: 11.Urology Times 50 Innovations Series: BCG therapy for bladder cancer

EP: 12.Urology Times 50 Innovations Series: Extracorporeal shock wave lithotripsy for stones

EP: 13.Urology Times 50 Innovations Series: Treatment of female hypoactive sexual desire disorder

EP: 14.Urology Times 50 Innovations Series: Cryotherapy for kidney and prostate cancer

EP: 15.Urology Times 50 Innovations Series: Intralesional therapies for Peyronie's disease

EP: 16.Urology Times 50 Innovations Series: Radiation therapy for prostate cancer

Now Viewing

EP: 17.Urology Times 50 Innovations Series: β3 agonists for overactive bladder

EP: 18.Urology Times 50 Innovations Series: Microsurgical testicular sperm extraction

EP: 19.Urology Times 50 Innovations Series: Anatomic radical prostatectomy

EP: 20.Urology Times 50 Innovations Series: Dr. Kelvin Moses on sipuleucel-T for mCRPC

EP: 21.Urology Times 50 Innovations Series: Dr. Jennifer Linehan on HIFU for prostate cancer

EP: 22.Urology Times 50 Innovations Series: Transrectal ultrasound-based prostate biopsy

EP: 23.Urology Times 50 Innovations Series: Neobladder reconstruction

EP: 24.Urology Times 50 Innovations Series: Multichannel urodynamics

EP: 25.Urology Times 50 Innovations Series: Treatments for male infertility

EP: 26.Urology Times 50 Innovations Series: Urinary molecular biomarkers in prostate cancer

EP: 27.Urology Times 50 Innovations Series: Blue light cystoscopy for the detection of bladder cancer

EP: 28.Urology Times 50 Innovations Series: LHRH analogues in prostate cancer

EP: 29.Urology Times 50 Innovations Series: Advancements in vesicovaginal fistula repair

EP: 30.Urology Times 50 Innovations Series: Artificial urinary sphincter

EP: 31.Urology Times 50 Innovations Series: PSMA-PET imaging in prostate cancer

EP: 32.Urology Times 50 Innovations Series: Sacral neuromodulation

EP: 33.Urology Times 50 Innovations Series: Penile prostheses

EP: 34.Urology Times 50 Innovations Series: Multiparametric MRI in prostate cancer

EP: 35.Urology Times 50 Innovations Series: Intracavernosal injections for erectile dysfunction

EP: 36.Urology Times 50 Innovations Series: Bulking injections for stress urinary incontinence

EP: 37.Dr. Gill explains the importance of BPH treatment innovations to urology

EP: 38.50th Anniversary Innovation Celebration: Buccal mucosa grafts for urethral strictures

Urology Times® is celebrating its 50th anniversary in 2022. To mark the occasion, we are highlighting 50 of the top innovations and developments that have transformed the field of urology over the past 50 years. In this installment, Ekene A. Enemchukwu, MD, MPH, discusses the development of β3 agonists for the treatment of overactive bladder (OAB). Enemchukwu is an assistant professor of urology and, by courtesy, of obstetrics and gynecology and medical director of the Stanford Pelvic Health Center, Stanford University, Palo Alto, California